FDA ap­proves Dai­ichi Sanky­o's new first-line AML drug quizar­tinib with boxed warn­ing for heart dis­or­ders

Pa­tients with a rar­er form of acute myeloid leukemia now have a front­line treat­ment op­tion for the first time, thanks to the FDA’s ap­proval of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA